Health
FDA conditionally approves first oral treatment for dogs with lymphoma – News-Medical.Net
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph…
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia-CA1 works to prevent certain proteins from leaving the nucleus of cancer cells, thereby allowing these proteins to control the growth and prevent the spread of cancerous cells in dogs.
Laverdia-CA1 is the first conditionally approved oral treatment for dogs with lymphoma. Because Laverdia-CA1 is orally…
-
Noosa News23 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General12 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
General15 hours agoCoalition to chart path forward as family feud cooled
-
General23 hours agoDavid Littleproud’s own goal • Inside Story